RLYB RALLYBIO CORP revenue, earnings and financials
For the quarter ended June 30, 2026, RALLYBIO CORP reported revenue of $0 (down 100.0% from a year earlier), net income of $43.7M and diluted EPS of $7.53; over the last four quarters revenue was $646K and net income $45.6M; for the fiscal year ended December 2025 revenue was $858K, up 34.9% on the year before.
RLYB annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $858K, gross profit n/a, operating income −$33.1M, net income −$8.98M (margin -1046.4%), EPS −$1.59
- Fiscal year ended Dec 2024: revenue $636K, gross profit n/a, operating income −$60.5M, net income −$57.8M (margin -9084.1%), EPS −$10.61
- Fiscal year ended Dec 2023: revenue n/a, gross profit n/a, operating income −$78.9M, net income −$74.6M (margin n/a), EPS −$1.84
- Fiscal year ended Dec 2022: revenue n/a, gross profit n/a, operating income −$67.9M, net income −$66.7M (margin n/a), EPS −$2.09
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$45.6M, net income −$47.0M (margin n/a), EPS −$1.84
RLYB quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $0 (down 100.0% year over year), net income $43.7M, EPS $7.53
- Quarter ended Mar 31, 2026: revenue $212K (up 0.0% year over year), net income −$8.28M, EPS −$1.46
- Quarter ended Dec 31, 2025 (from the annual report): revenue $222K (up 484.2% year over year), net income −$5.85M, EPS −$0.04
- Quarter ended Sep 30, 2025: revenue $212K (down 29.1% year over year), net income $16.0M, EPS $0.36
- Quarter ended Jun 30, 2025: revenue $212K (down 29.1% year over year), net income −$9.70M, EPS −$0.22
- Quarter ended Mar 31, 2025: revenue $212K, net income −$9.44M, EPS −$1.69
- Quarter ended Dec 31, 2024 (from the annual report): revenue $38.0K, net income −$11.0M, EPS −$9.51
- Quarter ended Sep 30, 2024: revenue $299K, net income −$11.5M, EPS −$0.26
- Quarter ended Jun 30, 2024: revenue $299K, net income −$16.2M, EPS −$0.37
- Quarter ended Mar 31, 2024: revenue $0, net income −$19.0M, EPS −$0.47
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$20.2M, EPS −$0.50
- Quarter ended Sep 30, 2023: revenue $0, net income −$18.4M, EPS −$0.45
- Quarter ended Jun 30, 2023: revenue $0, net income −$18.6M, EPS −$0.46
- Quarter ended Mar 31, 2023: revenue n/a, net income −$17.3M, EPS −$0.43
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$16.2M, EPS −$0.44
- Quarter ended Sep 30, 2022: revenue n/a, net income −$18.4M, EPS −$0.60
- Quarter ended Jun 30, 2022: revenue n/a, net income −$17.6M, EPS −$0.57
- Quarter ended Mar 31, 2022: revenue n/a, net income −$14.5M, EPS −$0.48
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$12.4M, EPS −$0.38
- Quarter ended Sep 30, 2021: revenue n/a, net income −$10.2M, EPS −$0.37
RLYB cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$29.8M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$49.3M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$60.3M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$57.3M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$45.5M, share buybacks n/a
RLYB balance sheet
- Jun 30, 2026: cash $92.8M, total assets $98.1M, total liabilities $3.57M, shareholders' equity $94.5M
- Mar 31, 2026: cash $41.3M, total assets $54.5M, total liabilities $4.20M, shareholders' equity $50.3M
- Dec 31, 2025: cash $31.4M, total assets $62.3M, total liabilities $4.31M, shareholders' equity $58.0M
- Sep 30, 2025: cash $32.1M, total assets $67.7M, total liabilities $4.63M, shareholders' equity $63.0M
- Jun 30, 2025: cash $9.45M, total assets $51.0M, total liabilities $5.04M, shareholders' equity $46.0M
- Mar 31, 2025: cash $14.8M, total assets $58.0M, total liabilities $3.91M, shareholders' equity $54.1M
- Dec 31, 2024: cash $13.9M, total assets $68.1M, total liabilities $6.45M, shareholders' equity $61.7M
- Sep 30, 2024: cash $25.3M, total assets $79.0M, total liabilities $8.19M, shareholders' equity $70.8M
What is RLYB's revenue?
RALLYBIO CORP reported $646K of revenue over its last four quarters, through June 30, 2026.
Is RLYB profitable?
Yes. RALLYBIO CORP earned $45.6M over the last four quarters.
What is RLYB's EPS?
Diluted earnings per share over the last four quarters were $6.39; $7.53 in the latest quarter.